GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $15.12 $17.25 Thursday, 18th Apr 2024 VRNA stock ended at $16.10. This is 1.83% less than the trading day before Wednesday, 17th Apr 2024. During the day the stock fluctuated 3.07% from a day low at $15.96 to a day high of $16.45.
90 days $15.12 $19.27
52 weeks $11.83 $23.81

Historical Verona Pharma plc prices

Date Open High Low Close Volume
2023-12-29 $20.41 $20.41 $19.81 $19.88 756 787
2023-12-28 $20.54 $21.31 $20.06 $20.16 779 527
2023-12-27 $20.36 $20.50 $19.59 $20.47 702 777
2023-12-26 $18.42 $20.15 $18.31 $19.99 1 629 459
2023-12-22 $16.73 $17.85 $16.70 $17.56 598 054
2023-12-21 $16.77 $16.78 $16.15 $16.37 263 930
2023-12-20 $17.48 $17.70 $16.55 $16.58 554 321
2023-12-19 $17.82 $18.20 $17.23 $17.48 457 732
2023-12-18 $17.55 $17.82 $17.12 $17.73 760 321
2023-12-15 $16.55 $17.29 $16.45 $17.27 1 001 481
2023-12-14 $15.33 $16.54 $14.95 $16.52 1 301 006
2023-12-13 $14.77 $15.12 $14.17 $15.12 354 778
2023-12-12 $14.20 $14.80 $14.10 $14.73 336 606
2023-12-11 $14.65 $14.65 $13.93 $14.20 540 168
2023-12-08 $13.67 $14.66 $13.41 $14.62 642 690
2023-12-07 $13.47 $14.12 $13.24 $13.67 426 130
2023-12-06 $13.43 $13.84 $13.32 $13.33 304 537
2023-12-05 $13.72 $13.84 $13.46 $13.49 352 450
2023-12-04 $13.65 $13.98 $13.29 $13.68 667 322
2023-12-01 $13.50 $13.58 $12.85 $13.52 483 694
2023-11-30 $13.25 $13.91 $13.11 $13.52 343 665
2023-11-29 $13.62 $13.81 $12.98 $13.10 495 086
2023-11-28 $14.12 $14.12 $13.40 $13.44 300 161
2023-11-27 $14.13 $14.17 $13.68 $13.86 303 507
2023-11-24 $14.23 $14.44 $14.10 $14.24 119 438
Click to get the best stock tips daily for free!

About Verona Pharma plc

Verona Pharma plc Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodilator and an anti-inflammatory agent in a single compound, which is in Phase 3 clinical trials for the ... VRNA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT